Edward Roffman is listed as a director on 10 SEC Form D filings by 1 issuer between Apr 2013 and Sep 2018: Icagen, Inc. (Durham, NC — pharmaceuticals — 2013–2018; $8.86M reported sold to 162 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Clive Kabatznik (8 shared filings), Mark Korb (8 shared filings), Michael N. Taglich (8 shared filings), Richard Cunningham (8 shared filings), Timothy Tyson (8 shared filings) and 4 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Edward. Each name links to their own page.
The issuer belongs to the sponsor group Icagen (2 issuers, $15.3M reported sold, 2011–2018).
What this means A sponsor group is one team that sets up a new company for each deal. Icagen has 2 companies on file and $15.3M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 10 public filings for Edward Roffman and found 10 differences: Form D filed 16 days after the first sale; Offering amount changed between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.